Salim Yazji Joins PMV Pharma as Chief Medical Officer

Xconomy Boston — 

PMV Pharmaceuticals has appointed Salim Yazji to serve as chief medical officer of the Cranbury, NJ, cancer drug developer. Yazji most recently worked at Calimmune, where he was executive vice president and chief medical officer. Yazji will be based in the Boston area, where PMV is opening a site for its clinical and regulatory operations. Last year, PMV raised $74 million to advance into clinical trials testing a drug targeting tumor suppressor protein p53.